As of 2026-06-05, AbbVie (ABBV) has an overall Buy technical signal, while Merck (MRK) reads Buy. Over the last six months ABBV returned +1.3% versus MRK at +22.4% (so MRK has outperformed on price). These are automated technical readings for education, not financial advice.
| Metric | ABBV | MRK |
|---|---|---|
| Price | $227.95 | $121.56 |
| Daily change | +1.34% | +1.08% |
| Overall signal | Buy | Buy |
| Confidence | 43% | 43% |
| 6-month return | +1.3% | +22.4% |
| RSI (14) | 70 | 61 |
| MACD | Buy | Buy |
| Trend | Uptrend | Uptrend |
AbbVie full analysis · Merck full analysis · Interactive chart →
⚠️ Not financial advice. Automated technical information for education only; indicators are not proven to beat buy-and-hold. © 2026 DailyTechnicals.